Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
108.3 USD | -1.23% | +1.14% | -11.93% |
Kurzporträt
Mitarbeiterzahl: 2 800
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 3 659 | 100,0 % | 3 834 | 100,0 % | +4.78% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
91,0
%
| 3 370 | 92,1 % | 3 490 | 91,0 % | +3.55% |
Europe
7,0
%
| 240 | 6,5 % | 269 | 7,0 % | +12.35% |
All Other
2,0
%
| 49 | 1,3 % | 75 | 2,0 % | +51.92% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01.03.03 |
Renée Galá
PSD | President | 52 | 16.03.20 |
Robert Iannone
CTO | Chief Tech/Sci/R&D Officer | 57 | 29.05.19 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18.01.12 |
Andrea N. Flynn
IRC | Investor Relations Contact | - | - |
Shawn Mindus
PRN | Corporate Officer/Principal | - | - |
John Miller
PRN | Corporate Officer/Principal | - | - |
Heidi Manna
HRO | Human Resources Officer | 53 | 01.11.18 |
Neena Patil
LAW | General Counsel | 49 | 01.07.19 |
Aislinn Doody
SEC | Corporate Secretary | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01.03.03 |
Norbert Riedel
BRD | Director/Board Member | 66 | 13.05.13 |
Patrick Enright
BRD | Director/Board Member | 62 | 01.01.09 |
Peter Gray
BRD | Director/Board Member | 69 | 08.05.13 |
Ken O'Keefe
BRD | Director/Board Member | 57 | 01.01.04 |
Rick Winningham
BRD | Director/Board Member | 64 | 01.01.10 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18.01.12 |
Heather McSharry
BRD | Director/Board Member | 62 | 02.05.13 |
Catherine Sohn
BRD | Director/Board Member | 71 | 27.07.12 |
Anne O’Riordan
BRD | Director/Board Member | 56 | 14.02.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 62 345 283 | 60 588 007 ( 97,18 %) | 0 | 97,18 % |
Unternehmenskontakt
Jazz Pharmaceuticals Plc
Waterloo Exchange Waterloo Road
4, Dublin
+353 1 634 7800
http://www.jazzpharmaceuticals.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Jazz Pharmaceuticals Ireland Ltd.
Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The private company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation. |
Pharmaceuticals: Major
|
Jazz Financing I DAC
|
Finance/Rental/Leasing
|
Jazz Securities DAC
|
Finance/Rental/Leasing
|
Jazz Investments II Ltd.
|
Finance/Rental/Leasing
|
Jazz Financing Lux SARL
Jazz Financing Lux SARL Finance/Rental/LeasingFinance Part of Jazz Pharmaceuticals Plc, Jazz Financing Lux SARL provides financing services. The private company is based in Luxembourg, Luxembourg. Founded in 2013. |
Finance/Rental/Leasing
|
Jazz Investments Europe Ltd.
| |
Jazz Pharmaceuticals Ireland Holdings Ltd.
| |
Jazz Financing Holdings Ltd.
|
Sektor
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-11.93% | 6.75 Mrd. | |
+25.61% | 660 Mrd. | |
+25.87% | 562 Mrd. | |
-5.24% | 358 Mrd. | |
+16.49% | 322 Mrd. | |
+8.28% | 297 Mrd. | |
+7.09% | 219 Mrd. | |
-9.12% | 196 Mrd. | |
+5.01% | 199 Mrd. | |
-8.75% | 149 Mrd. |
- Börse
- Aktien
- A1JS1K Aktie
- Unternehmen Jazz Pharmaceuticals plc